CIM
GSK icon

Calvert Investment Management’s GSK GSK Stock Holding History

Calvert Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-50,482
Closed -$2.43M – 241
2016
Q4 		$2.43M Sell
50,482
-4,139
-8% -$204K 0.09% 271
2016
Q3 		$2.94M Sell
54,621
-43,695
-44% -$2.4M 0.11% 247
2016
Q2 		$5.33M Sell
98,316
-23,280
-19% -$1.23M 0.21% 129
2016
Q1 		$6.16M Hold
121,596
– – 0.27% 83
2015
Q4 		$6.13M Buy
121,596
+4,960
+4% +$253K 0.28% 70
2015
Q3 		$5.61M Buy
116,636
+3,706
+3% +$193K 0.28% 86
2015
Q2 		$5.88M Buy
112,930
+58,385
+107% +$3.29M 0.26% 90
2015
Q1 		$3.15M Buy
54,545
+4,539
+9% +$260K 0.2% 125
2014
Q4 		$2.67M Buy
50,006
+2,177
+5% +$122K 0.18% 135
2014
Q3 		$2.75M Buy
47,829
+507
+1% +$31.1K 0.2% 128
2014
Q2 		$3.16M Buy
47,322
+3,406
+8% +$231K 0.21% 110
2014
Q1 		$2.93M Sell
43,916
-19,280
-31% -$1.3M 0.21% 109
2013
Q4 		$4.22M Sell
63,196
-52,633
-45% -$3.41M 0.31% 93
2013
Q3 		$7.26M Sell
115,829
-2,800
-2% -$180K 0.9% 35
2013
Q2 		$7.41M Buy
+118,629
New +$7.53M 1.01% 29

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Calvert Investment Management's GSK Position: Q1 2017 in Review

Calvert Investment Management sold out of GSK (GSK) in Q1 2017, closing a stake of 50,482 shares — an estimated $2.43M sold.

Calvert Investment Management first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $7.41M in Q2 2013. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

  • Calvert Investment Management reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 50,482 GSK shares in Q1 2017, an estimated $2.43M.
  • Calvert Investment Management first reported a position in GSK in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's GSK position peaked at $7.41M in Q2 2013.
  • 786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.